Table 4 Patient characteristics based on the type of surgical intervention.
Sublobar resection# | Lobectomy | P-value | |
|---|---|---|---|
Subjects, n (%) | 75 (49.3) | 77 (50.7) | |
Age, years | 74.4 ± 7.2 | 71.5 ± 7.5 | 0.023* |
Sex, male/female | 65/10 | 61/16 | 0.221 |
Smoking history, pack-years | 46 (30.8–71.3) | 50 (30.0–65.3) | 0.883 |
VC, % predicted | 88.6 ± 19.2 | 92.9 ± 12.4 | 0.105 |
FVC, % predicted | 86.5 ± 17.6 | 89.3 ± 12.4 | 0.262 |
FEV1, % predicted | 86.7 ± 19.6 | 89.0 ± 16.0 | 0.426 |
FEV1/FVC, % | 76.4 ± 11.2 | 75.1 ± 9.5 | 0.431 |
DLco, % predicted | 52.7 ± 17.8 | 60.2 ± 16.2 | 0.008* |
ILD pattern | 0.270 | ||
UIP | 29 | 19 | |
Probable UIP | 7 | 10 | |
Indeterminate UIP | 23 | 25 | |
Alternative diagnosis | 16 | 23 | |
Preoperative steroid use, + /− | 8/67 | 7/70 | 0.745 |
Preoperative pirfenidone use, + /− | 5/70 | 1/76 | 0.089 |
Histology | 0.220 | ||
Adenocarcinoma | 32 | 36 | |
Squamous cell carcinoma | 32 | 24 | |
Small cell carcinoma | 6 | 5 | |
Others | 5 | 12 | |
pStage, I/II/IIIA/IIIB | 65/5/4/1 | 54/12/9/2 | 0.100 |
Primary tumor size, mm | 18 (12–28) | 29 (21–39) | < 0.001* |
Operative time, min | 139 (77–182) | 159 (124–209) | 0.006* |
Bleeding volume, mL | 47 (15–85) | 80 (41–140) | < 0.001* |
Incidence of postoperative AE-ILD, n (%) | 7 (9.3) | 10 (13.0) | 0.473 |